高级检索
    李颖, 刘强, 陈小清. PD-1抑制剂派姆单抗治疗晚期三阴性乳腺癌的疗效[J]. 循证医学, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
    引用本文: 李颖, 刘强, 陈小清. PD-1抑制剂派姆单抗治疗晚期三阴性乳腺癌的疗效[J]. 循证医学, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
    shu
    LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
    Citation: LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
    shu

    PD-1抑制剂派姆单抗治疗晚期三阴性乳腺癌的疗效

    Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients

      摘要
      • HTML全文
      • 参考文献(4)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回